89ZrTrastuzumab Breast Imaging With Positron Emission Tomography
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 89Zr-Trastuzumab Human Dosimetry and Safety|DRUG: HER2 Positive Lesion Detection and Safety
Sponsor: Washington University School of Medicine
Collaborators: National Cancer Institute (NCI)